3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumor
1
Advanced Solid Tumors
1
Interventions
Gemcitabine
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Cyclophosphamide
3
romidepsin
2
pembrolizumab
2
duvelisib
2
Vincristine
2
Prednisone
2
Biopsy
2
Azacitidine
2
tazemetostat
1
spartalizumab
1
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
sintilimab
1
ruxolitinib
1
ixazomib
1
ivarmacitinib
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
cabiralizumab
1
belinostat
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Specimen Handling
1
Prednisolone
1
Photons
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
WW Domain-Containing Oxidoreductase
×
90 days
×
Clear all
No trials found.